BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18344642)

  • 1. Sarcoidosis in the setting of idiopathic chronic bronchiolitis with airway colonization from P. aeruginosa: treatment with low-dose macrolides.
    Trisolini R; Cancellieri A; Paioli D; Burzi M; Orlandi P; Patelli M
    Intern Med; 2008; 47(6):537-42. PubMed ID: 18344642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections.
    Kobayashi H
    Treat Respir Med; 2005; 4(4):241-53. PubMed ID: 16086598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors.
    Tateda K; Standiford TJ; Pechere JC; Yamaguchi K
    Curr Pharm Des; 2004; 10(25):3055-65. PubMed ID: 15544497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse panbronchiolitis--pathophysiology and treatment mechanisms.
    Yanagihara K; Kadoto J; Kohno S
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S83-7. PubMed ID: 11574201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of diffuse panbronchiolitis and sarcoidosis revealed during splenectomy: a case report.
    Akaba T; Takeyama K; Kondo M; Kobayashi F; Okabayashi A; Sawada T; Tagaya E
    BMC Pulm Med; 2020 Mar; 20(1):77. PubMed ID: 32228530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiology of chronic airway infections].
    Kadota J
    Nihon Naika Gakkai Zasshi; 2006 Dec; 95(12):2559-65. PubMed ID: 17240889
    [No Abstract]   [Full Text] [Related]  

  • 8. Diffuse panbronchiolitis: role of macrolides in therapy.
    Keicho N; Kudoh S
    Am J Respir Med; 2002; 1(2):119-31. PubMed ID: 14720066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
    Reinert P
    Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic bronchiolitis mimicking diffuse panbronchiolitis.
    Poletti V; Chilosi M; Trisolini R; Cancellieri A; Zompatori M; Lazzari Agli L; Boaron M; Schulte W; Theegarten D; Guzman J; Costabel U
    Sarcoidosis Vasc Diffuse Lung Dis; 2003 Mar; 20(1):62-8. PubMed ID: 12737282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
    Bush A
    Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Pseudomonas aeruginosa quorum-sensing systems by macrolides: a promising strategy or an oriental mystery?
    Tateda K; Ishii Y; Kimura S; Horikawa M; Miyairi S; Yamaguchi K
    J Infect Chemother; 2007 Dec; 13(6):357-67. PubMed ID: 18095083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection.
    Fujii T; Kadota J; Kawakami K; Iida K; Shirai R; Kaseda M; Kawamoto S; Kohno S
    Thorax; 1995 Dec; 50(12):1246-52. PubMed ID: 8553295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases.
    Kudoh S
    Am J Med; 2004 Nov; 117 Suppl 9A():12S-19S. PubMed ID: 15586559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of macrolides to diffuse panbronchiolitis].
    Kudoh S
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():554-8. PubMed ID: 17455680
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.
    Hiratsuka T; Mukae H; Iiboshi H; Ashitani J; Nabeshima K; Minematsu T; Chino N; Ihi T; Kohno S; Nakazato M
    Thorax; 2003 May; 58(5):425-30. PubMed ID: 12728165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolides for diffuse panbronchiolitis.
    Lin X; Lu J; Yang M; Dong BR; Wu HM
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007716. PubMed ID: 25618845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolides for diffuse panbronchiolitis.
    Yang M; Dong BR; Lu J; Lin X; Wu HM
    Cochrane Database Syst Rev; 2013 Feb; (2):CD007716. PubMed ID: 23450579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of macrolides on airway microbiome and cytokine of children with bronchiolitis: A systematic review and meta-analysis of randomized controlled trials.
    Zhang Y; Dai J; Jian H; Lin J
    Microbiol Immunol; 2019 Sep; 63(9):343-349. PubMed ID: 31283028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An answer to an inquiry on diffuse panbronchiolitis. Now it has found its way here!].
    Naalsund A; Foerster A; Aasebø U; Kearney M; Boe J
    Lakartidningen; 1995 Aug; 92(35):3119-21. PubMed ID: 7658766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.